Carroll Financial Associates’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $414K | Sell |
3,338
-161
| -5% | -$21.1K | 0.02% | 272 |
|
|
2021
Q3 | $497K | Sell |
3,499
-5
| -0.1% | -$736 | 0.03% | 256 |
|
|
2021
Q2 | $547K | Sell |
3,504
-79
| -2% | -$12.8K | 0.03% | 244 |
|
|
2021
Q1 | $556K | Buy |
3,583
+35
| +1% | +$5.42K | 0.03% | 237 |
|
|
2020
Q4 | $530K | Buy |
3,548
+8
| +0.2% | +$1.13K | 0.04% | 235 |
|
|
2020
Q3 | $467K | Sell |
3,540
-306
| -8% | -$40K | 0.04% | 224 |
|
|
2020
Q2 | $445K | Hold |
3,846
| – | – | 0.04% | 235 |
|
|
2020
Q1 | $377K | Buy |
3,846
+1,030
| +37% | +$135K | 0.04% | 228 |
|
|
2019
Q4 | $409K | Sell |
2,816
-250
| -8% | -$34.5K | 0.03% | 245 |
|
|
2019
Q3 | $408K | Hold |
3,066
| – | – | 0.04% | 242 |
|
|
2019
Q2 | $350K | Buy |
3,066
+212
| +7% | +$24.8K | 0.03% | 258 |
|
|
2019
Q1 | $353K | Hold |
2,854
| – | – | 0.03% | 235 |
|
|
2018
Q4 | $287K | Sell |
2,854
-206
| -7% | -$23.2K | 0.03% | 224 |
|
|
2018
Q3 | $390K | Buy |
3,060
+2
| +0.1% | +$238 | 0.04% | 205 |
|
|
2018
Q2 | $330K | Sell |
3,058
-124
| -4% | -$13.5K | 0.04% | 220 |
|
|
2018
Q1 | $336K | Buy |
3,182
+210
| +7% | +$24.4K | 0.04% | 218 |
|
|
2017
Q4 | $348K | Hold |
2,972
| – | – | 0.04% | 211 |
|
|
2017
Q3 | $343K | Buy |
2,972
+107
| +4% | +$12.4K | 0.04% | 208 |
|
|
2017
Q2 | $357K | Buy |
2,865
+309
| +12% | +$36.6K | 0.04% | 205 |
|
|
2017
Q1 | $303K | Sell |
2,556
-42
| -2% | -$4.76K | 0.04% | 213 |
|
|
2016
Q4 | $260K | Hold |
2,598
| – | – | 0.04% | 215 |
|
|
2016
Q3 | $327K | Hold |
2,598
| – | – | 0.05% | 182 |
|
|
2016
Q2 | $303K | Hold |
2,598
| – | – | 0.05% | 182 |
|
|
2016
Q1 | $268K | Hold |
2,598
| – | – | 0.05% | 190 |
|
|
2015
Q4 | $258K | Buy |
2,598
+103
| +4% | +$10.1K | 0.05% | 175 |
|
|
2015
Q3 | $234K | Buy |
2,495
+149
| +6% | +$14.9K | 0.05% | 180 |
|
|
2015
Q2 | $249K | Buy |
2,346
+1,069
| +84% | +$118K | 0.06% | 171 |
|
|
2015
Q1 | $146K | Hold |
1,277
| – | – | 0.06% | 159 |
|
|
2014
Q4 | $143K | Sell |
1,277
-1,069
| -46% | -$113K | 0.09% | 133 |
|
|
2014
Q3 | $253K | Hold |
2,346
| – | – | 0.08% | 135 |
|
|
2014
Q2 | $237K | Buy |
2,346
+1
| +0% | +$98 | 0.07% | 153 |
|
|
2014
Q1 | $215K | Sell |
2,345
-1
| -0% | -$92 | 0.07% | 145 |
|
|
2013
Q4 | $212K | Buy |
2,346
+207
| +10% | +$17.9K | 0.08% | 140 |
|
|
2013
Q3 | $170K | Sell |
2,139
-7,126
| -77% | -$561K | 0.06% | 153 |
|
|
2013
Q2 | $674K | Buy |
+9,265
| New | +$693K | 0.33% | 58 |
|
Other funds holding ZBH
Carroll Financial Associates's ZBH Position: Q4 2021 in Review
Carroll Financial Associates reduced its Zimmer Biomet (ZBH) stake by 4.6% in Q4 2021, selling an estimated $21.1K and leaving 3,338 shares worth $414K. The position accounts for 0.02% of the portfolio, ranked #272.
Carroll Financial Associates first reported a position in ZBH in Q2 2013 and has held it in 35 quarters since. The position peaked at $674K in Q2 2013. 998 funds tracked by Wall St. Rank hold ZBH as of Q4 2021.
- Carroll Financial Associates held 3,338 shares of Zimmer Biomet worth $414K as of Q4 2021.
- Carroll Financial Associates sold 161 Zimmer Biomet shares in Q4 2021, an estimated $21.1K.
- Zimmer Biomet made up 0.02% of Carroll Financial Associates's portfolio in Q4 2021, its #272 holding.
- Carroll Financial Associates first reported a position in Zimmer Biomet in Q2 2013 and has held it in 35 quarters since.
- Carroll Financial Associates's Zimmer Biomet position peaked at $674K in Q2 2013.
- 998 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2021.
Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.